Akèy › Kat vèt › Carl Zeiss Meditec, Inc.
Carl Zeiss Meditec, Inc.: sponso kat vèt (PERM)
Carl Zeiss Meditec, Inc. te depoze 5 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 5. Mwayèn salè yo ofri $108,000; mwayèn tan soti nan depozisyon jiska sètifikasyon: 475 jou.
Aplikasyon PERM5
Sètifye5
Salè medyan ofri$108,000
Mwayèn jou pou sètifikasyon475
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)332
Nan biznis depi1971
Adrès anplwayèDublin, CA
Salè H-1B nan Carl Zeiss Meditec, Inc. →
Tit travay
| Tit travay | Aplikasyon PERM | Salè medyan |
|---|---|---|
| Senior Scientist | 1 | $94,000 |
| Senior Financial Analyst | 1 | $80,000 |
| Product Marketing Specialist | 1 | $108,000 |
| Threat and Vulnerability Manager | 1 | $158,000 |
| Senior ERP Business Analyst | 1 | $172,000 |
Kote travay
Okipasyon
- Medical Scientists, Except Epidemiologists1
- Financial and Investment Analysts1
- Market Research Analysts and Marketing Specialists1
- Information Security Analysts1
- Computer Systems Analysts1
Dènye desizyon
| Tit travay | Salè baz | Kote | Soumèt | Deside | Estati | Jou |
|---|---|---|---|---|---|---|
| Senior ERP Business Analyst | $172,000–$175,000 | Dublin, CA | Jun 16, 2025 | Jun 30, 2026 | Sètifye | 379 |
| Threat and Vulnerability Manager | $158,000–$163,000 | Dublin, CA | Feb 13, 2025 | May 8, 2026 | Sètifye | 449 |
| Product Marketing Specialist | $108,000–$145,000 | Dublin, CA | Apr 3, 2024 | Jul 24, 2025 | Sètifye | 477 |
| Senior Financial Analyst | $80,000–$107,000 | Dublin, CA | Dec 26, 2023 | Apr 14, 2025 | Sètifye | 475 |
| Senior Scientist | $94,000–$154,000 | Dublin, CA | Dec 1, 2023 | Apr 14, 2025 | Sètifye | 500 |
Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).